Kurt W Naujoks

Title: Kurt W Naujoks: Innovator in Medical Science

Introduction

Kurt W Naujoks is a notable inventor based in Gauting, Germany. He has made significant contributions to the field of medical science, particularly in the area of regenerative medicine and cancer diagnostics. With a total of 6 patents to his name, Naujoks has developed innovative methods that have the potential to improve patient outcomes in various medical conditions.

Latest Patents

One of Naujoks' latest patents is focused on the in vivo regeneration of oligodendrocytes through the bolus injection of human β nerve growth factor (NGF-β). This method aims to regenerate oligodendrocytes in diseases such as multiple sclerosis by administering 1-10 bolus injections at a dosage of 0.05 to 5.0 µg/kg body weight, with intervals ranging from 1 to 21 days. Another significant patent involves monoclonal antibodies against the human c-kit receptor, which are derived from specific cell lines. This invention also includes a method for detecting malignancies in tumors of hematopoietic cells, seminomas, or small-celled lung carcinoma using these antibodies.

Career Highlights

Throughout his career, Kurt W Naujoks has worked with prominent companies in the medical field, including Boehringer Mannheim GmbH and Roche Diagnostics GmbH. His experience in these organizations has contributed to his expertise and innovative capabilities in medical research and development.

Collaborations

Naujoks has collaborated with notable colleagues such as Ilse Bartke and Karl Wulff. These partnerships have likely enhanced his research efforts and led to the development of groundbreaking medical technologies.

Conclusion

Kurt W Naujoks is a distinguished inventor whose work in regenerative medicine and cancer diagnostics has the potential to make a significant impact on healthcare. His innovative patents and collaborations reflect his commitment to advancing medical science.